Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
Shuyu Hao, Guanyou Huang, Jie Feng, et al.
Journal of Neuro-Oncology (2019) Vol. 144, Iss. 1, pp. 11-20
Closed Access | Times Cited: 24

Showing 24 citing articles:

Tryptophan metabolism in health and disease
Xue Chen, Ganglei Li, Qiuxian Zheng, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1304-1326
Open Access | Times Cited: 317
The therapeutic potential of targeting tryptophan catabolism in cancer
Christiane A. Opitz, Luis F. Somarribas Patterson, Soumya R. Mohapatra, et al.
British Journal of Cancer (2019) Vol. 122, Iss. 1, pp. 30-44
Open Access | Times Cited: 221
Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors
Andrew D. Miller, C. Ryan Miller, John H. Rossmeisl
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 97
Tryptophan metabolism in brain tumors — IDO and beyond
Michael Platten, Mirco Friedrich, Derek A. Wainwright, et al.
Current Opinion in Immunology (2021) Vol. 70, pp. 57-66
Open Access | Times Cited: 41
Basis for Immunotherapy for Treatment of Meningiomas
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
Tryptophan Metabolism Disorder-Triggered Diseases, Mechanisms, and Therapeutic Strategies: A Scientometric Review
Xue Chen, Dong Xu, Jie Yu, et al.
Nutrients (2024) Vol. 16, Iss. 19, pp. 3380-3380
Open Access | Times Cited: 5
Genomic Biomarkers of Meningioma: A Focused Review
Jacob Pawloski, Hassan Fadel, Yi‐Wen Huang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10222-10222
Open Access | Times Cited: 22
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 3, pp. 443-449
Open Access | Times Cited: 18
Evolving concepts in meningioma management in the era of genomics
Annie L. Hsieh, Wenya Linda Bi, Vijaya Ramesh, et al.
Cancer (2024) Vol. 130, Iss. 15, pp. 2586-2600
Open Access | Times Cited: 2
Advances in Multidisciplinary Management of Skull Base Meningiomas
Tamara Ius, Alessandro Tel, Giuseppe Minniti, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2664-2664
Open Access | Times Cited: 16
The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas
Giuseppe Roberto Giammalva, Lara Brunasso, Federica Paolini, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3639-3639
Open Access | Times Cited: 12
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
Alessia Pellerino, Francesco Bruno, Rosa Palmiero, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2256-2256
Open Access | Times Cited: 11
Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas
Lan Jin, Mark W. Youngblood, Trisha Gupte, et al.
Journal of Neuro-Oncology (2021) Vol. 154, Iss. 2, pp. 237-246
Closed Access | Times Cited: 13
A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base
Nina Martinez, Omaditya Khanna, Christopher Farrell
Chinese Clinical Oncology (2020) Vol. 9, Iss. 6, pp. 75-75
Open Access | Times Cited: 13
A Review of the Role of Stereotactic Radiosurgery and Immunotherapy in the Management of Primary Central Nervous System Tumors
Eric J. Lehrer, Brianna M. Jones, Kunal K. Sindhu, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2977-2977
Open Access | Times Cited: 7
Rare Tumor-to-Tumor Metastases Involving Lung Adenocarcinoma to Petroclival Meningiomas
Samuel Mansour, Evan Luther, Nikolas Echeverry, et al.
World Neurosurgery (2020) Vol. 144, pp. 125-135
Closed Access | Times Cited: 9
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
María González-Tablas, Carlos Alberto Vanegas Prieto, D. Arandia, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
Nivedha Kannapadi, Pavan P. Shah, Dimitrios Mathios, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Prognostic model construction and immune microenvironment analysis of esophageal cancer based on gene expression data and microRNA target genes
Bingbing Gu, Shuai Zhang, Zhe Fan, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 5, pp. 1165-1174
Open Access | Times Cited: 2
Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing
Junhyung Kim, Kihwan Hwang, Hyun Jung Kwon, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry
İsmail Sayğın, Emel Çakır, Seher Nazlı Kazaz, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2024) Vol. 54, Iss. 4, pp. 735-743
Open Access
Biomolecular-Related Medical Therapy for Meningiomas
Alessia Pellerino, Francesco Bruno, Edoardo Pronello, et al.
(2024), pp. 177-185
Closed Access
TRAF7 somatic mosaicism in a patient with bilateral optic nerve sheath meningiomas: illustrative case
Georgia Kaidonis, Melike Pekmezci, Jessica Van Ziffle, et al.
Journal of Neurosurgery Case Lessons (2022) Vol. 3, Iss. 23
Open Access | Times Cited: 1
Meningiomas and the tumor microenvironment: expression of PD-L1 and expression of PD-L1 and interferon-gamma in the prognosis
Gunter Gerson, Paulo G. B. Silva, Carlos Eduardo Lopes Soares, et al.
Jornal Brasileiro de Patologia e Medicina Laboratorial (2020)
Open Access
Page 1

Scroll to top